NEW YORK, Jan. 11, 2016 -- The JDD (Journal of Drugs in Dermatology) will honor dermatologists and companies with the JDD Leaders of Distinction Awards at the Orlando Dermatology Aesthetic and Clinical (ODAC) Conference in Orlando, Florida, January 15-18, 2016. The JDD Leaders of Distinction Awards recognizes dermatologists, residents, companies and/or organizations for their contributions to the field of dermatology.
Ron G. Wheeland, MD, will be recognized for Outstanding Leadership in Dermatology Education and Research. Dr. Wheeland’s research has led to an improved understanding of how lasers interact with the skin and how best to use those devices. He has also performed numerous clinical research projects that have improved the care of patients with chronic wounds, various vascular conditions, skin cancer and excess hair.
Brett Coldiron, MD, will be honored for Outstanding Leadership in Promoting the Field of Dermatology. Dr. Coldiron is a past president of both the American College of Mohs Surgery and the American Academy of Dermatology. He has published more than 63 peer-reviewed articles and four book chapters.
Jill S. Waibel, MD, will be awarded the Humanitarian Award, which recognizes outstanding leaders within the field of dermatology who have gone above and beyond by donating their time and services to improve patient outcomes. Dr. Waibel is honored for her innovative work in using lasers to treat patients with traumatic burn injuries.
Robin Lewallen, MD, will be named Resident of the Year. Dr. Lewallen was voted her program’s Resident Teacher of the Year for every year of her residency. She is co-editor of a book on contact dermatitis and is currently co-authoring a second book, Illustrated Clinical Cases: Dermatology. She volunteers at a free clinic and community health fairs, and serves on the resident quality improvement council.
JDD will also recognize the following companies at ODAC for their contributions to the field of dermatology. The Future of Dermatology Award will be presented to Genentech, and The Leader in Scientific Achievement Award will go to Allergan/KYTHERA® Biopharmaceuticals.
Full details of the winners can be found here: jddonline.com/jddawards.About JDD (Journal of Drugs in Dermatology)
A product of SanovaWorks, JDD (Journal of Drugs in Dermatology) is a full-color, peer-reviewed publication indexed with MEDLINE®/PubMed®. Founded by Perry Robins, MD, and now in its 15th volume, JDD presents original articles, award-winning case reports, and timely features pertaining to new methods, techniques, and drug therapy in dermatology. Articles are reviewed by an International Editorial Board of more than 160 experts, led by Co-Editors-in-Chief Perry Robins, MD, and Deborah S. Sarnoff, MD. JDD has also been recognized as the official publication of the International Society of Dermatologic Surgery (ISDS), the Skin of Color Seminar Series (SOCSS) and the Orlando Dermatology Aesthetic and Clinical (ODAC) Conference.About Orlando Dermatology Aesthetic and Clinical Conference (ODAC)
Since 2003, ODAC has presented the leading medical, surgical and cosmetic educational programs delivered by the foremost thought leaders in dermatology. With more than 27 hours of CME/CE credits available, attendees experience first-hand the next generation of cutting-edge procedures, products, and techniques designed to better serve patients, enhance their practice, and collectively define the future of dermatology. ODAC is managed exclusively by SanovaWorks, a New York-based healthcare communications company.
Journal of Drugs in Dermatology